Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A B-lymphoblastic leukemia/lymphoma that is characterized by amplification of a portion of chromosome 21.
No clinical trials have been registered for B-lymphoblastic leukemia/lymphoma with IAMP21.
1 publication has been identified in PubMed for B-lymphoblastic leukemia/lymphoma with IAMP21. Research spans Basic Science / Preclinical (100%).
Suurenbroek LC (2026). [PMID: 41952634](https://pubmed.ncbi.nlm.nih.gov/41952634/). *Haematologica*. [Basic Science / Preclinical]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 8:41 AM UTC
Common questions about B-lymphoblastic leukemia/lymphoma with IAMP21